Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Principal Investigator
Mengya Zhao, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$150,000
Active Dates
July 01, 2024 - June 30, 2026
Grant ID
G2024005F
Mentor(s)
Xin Duan, PhD, University of California, San Francisco
Goals
Summary
Unique and Innovative
This proposal uniquely integrates spatial transcriptomics with advanced genetic manipulations to investigate retinal ganglion cell degeneration, maintaining cellular context to unravel glaucoma’s complex molecular landscape. Employing MERFISH allows for unprecedented visualization of RGC transcriptomes in situ, enhancing understanding of cell-specific responses to stress and potential neuroprotective mechanisms. This approach pioneers a comprehensive, spatially-resolved exploration of glaucoma pathophysiology.
Foreseeable Benefits
Upon completion, this study is expected to offer novel insights into the cellular mechanisms of glaucoma, paving the way for targeted therapies that can potentially halt or reverse vision loss. The integration of spatial transcriptomics could also set a new standard for studying neurodegenerative diseases more broadly, benefiting both clinical approaches and basic neurological research.
Related Grants
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine